The Vanguard Group, Inc. has recently announced that it has increased stake in Ocugen Inc (NASDAQ:OCGN) by 1.02%. After grabbing 11.8 million shares, the institutional investor is now in possession of 0.12 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.60% having worth around $4.57 million. Moreover, Northern Trust Investments, Inc. increased its share by 55113.0 to have a control over 0.44 million shares.
Ocugen Inc (OCGN) concluded trading on 01/10/24 at a closing price of $0.59, with 3.23 million shares of worth about $1.91 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.27% during that period and on Wednesday the price saw a loss of about -9.61%. Currently the company’s common shares owned by public are about 256.50M shares, out of which, 250.57M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vanguard Total Stock Market ETF, Vanguard Extended Market Index Fu, and JPMorgan Funds – Thematics – Gene are the top 3 mutual funds which are holding stakes in Ocugen Inc Vanguard Total Stock Market ETF is currently holding 7.6 million shares of worth totaling $2.94 million. The company recently came buying 0.0 shares which brought its stake up to 2.96% of the company’s outstanding shares. Vanguard Extended Market Index Fu bought 41001.0 shares, after which its hold over company’s outstanding shares expand to 1.21%, leaving 3.11 million shares with the mutual fund that have a worth of about $1.2 million. JPMorgan Funds – Thematics – Gene, after selling 3.01 million shares, have now control over 1.18% of the stake in the company. It holds 78891.0 shares of worth $1.17 million.
Stock saw a price change of -10.37% in past 5 days and over the past one month there was a price change of 50.62%. Year-to-date (YTD), OCGN shares are showing a performance of 1.79% which decreased to -53.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.34 but also hit the highest price of $1.40 during that period. The average intraday trading volume for Ocugen Inc shares is 2.51 million. The stock is currently trading 17.22% above its 20-day simple moving average (SMA20), while that difference is up 36.74% for SMA50 and it goes to 11.23% higher than SMA200.
The Vanguard Group, Inc. acquired 11.8 million shares of Ocugen Inc having value of about $4.57 million. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 0.12 million shares in the company valued at close to $70332.13, or have control over 1.02% stake in the company. Ocugen Inc (NASDAQ: OCGN) currently have 256.50M outstanding shares and institutions hold larger chunk of about 12.91% of that. Holding of mutual funds in the company is about 5.76% while other institutional holders and individual stake holders have control over 7.15% and 2.66% of the stake respectively.
The stock has a current market capitalization of $150.13M and its 3Y-monthly beta is at 3.27. It has posted earnings per share of -$0.32 in the same period. It has Quick Ratio of 5.08 while making debt-to-equity ratio of 0.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OCGN, volatility over the week remained 8.37% while standing at 8.67% over the month.
Analysts are in expectations that Ocugen Inc (OCGN) stock would likely to be making an EPS of -$0.06 in the current quarter, while forecast for next quarter EPS is -$0.06 and it is -$0.27 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.07 which is -$0.06 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.1 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 25.44%.
Analysts at 4 brokerage firms have issued recommendations for the Ocugen Inc (OCGN)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 4 Wall Street analysts, 4 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Chardan Capital Markets on March 01, 2023 offering a Buy rating for the stock and assigned a target price of $3.50 to it.
